Delivery Order SPE2DB22D9353-SPE2DB23FX2FF
Award Date 7/25/23
Potential Completion Date 8/15/23
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DOD) awarded a $77,370 delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The firm fixed price order is being performed in Park Ridge, Illinois under contract number 4561452920 from July 6th to July 27th, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies, likely including this order for the injectable medication Xolair...
- The Defense Logistics Agency awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561367155 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between June 26, 2023 and July 18, 2023. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other necessary supplies, this delivery order will provide the military with Xolair, a medication used to treat asthma and chronic idiopathic...
- The Defense Logistics Agency awarded a $9,813 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4558369217 XOLAIR 150 MG/ML SYRINGEML. The contract has a period of performance from September 1, 2022 through September 23, 2022 and will be performed in Park Ridge, Illinois. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to provide the specified medication in support of DoD health programs. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a $2,321.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 4562280330 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between September 20 and October 12, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring medical supplies and pharmaceuticals to support military treatment facilities and readiness programs. No...
- The Defense Logistics Agency awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The prime contractor will deliver the pharmaceutical products to a location in Park Ridge, Illinois by September 6, 2023 in support of DLA requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to supply pharmaceuticals and medical supplies for various Department...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for pharmaceutical product 4561503464, identified as XOLAIR 150 MG/ML SYRINGEML. Performance will take place in Park Ridge, Illinois over a three week period concluding on August 3, 2023. The delivery order was issued against an unidentified indefinite-delivery/indefinite-quantity contract vehicle to supply the product in support of the Agency's medical materiel programs. No set...
- The Defense Logistics Agency awarded a delivery order valued at $69,633 to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The contract will be performed in Park Ridge, Illinois over a period of three weeks concluding on August 29, 2023. It utilizes a firm fixed price contract type. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, construction and...
- The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The start date is July 6, 2023 and the end date is July 27, 2023. No set aside designation or subcontractors are indicated. The DLA procures and provides logistics support for medical supplies and equipment for the Department of Defense and other federal agencies, so this order is likely...
- The Defense Logistics Agency awarded a $38,685 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide the specified medication to DLA locations in Park Ridge, Illinois, with performance required between July 18th and August 8th of 2023. No set aside designation or subcontracting details were indicated. This order...
- The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from August 29, 2023 through September 20, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing supplies, equipment, and weapon systems for the armed forces and other government...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB23FX2FFDelivery Order
The Defense Logistics Agency awarded a $13,926.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4561624525 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract has a period of performance from July 25, 2023 through August 15, 2023, with work taking place in Park Ridge, Illinois. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to procure the medication Xolair, used to treat allergic conditions including asthma. No subcontractors or set aside designations were indicated.
Generated 12/19/23, 10:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 7/25/23 |